Skip to main content
OpenTrials
Completed

NCT Number: NCT01713933

Evaluation of the Ulthera® System for Treatment of the Brachia

This study is an evaluation of the Ulthera® System used to treat the upper arms for improvement of brachial ptosis. All enrolled subjects will receive one bilateral upper arm treatment. Follow-up visits will occur at 60, 90 and 180 days post-treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

19 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sasaki Advanced Aesthetic Medical Center

Pasadena, California, 91105, United States

About this study

This is a prospective, non-randomized, clinical trial treating up to 35 subjects. Study photographs of the upper arms will be taken prior to treatment, immediately post-treatment, and at each follow-up visit. Brachial volume and dermal thickness measurements will be obtained.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female, aged 19 - 55 years.
  • Subject in good health.
  • Subjects who desire lift and tightening of the brachia and improvement in skin laxity.
  • Mild to moderate laxity of the upper arm.
  • Mild to moderate subcutaneous fat of the upper arm.
  • Mild crepiness of the skin of the upper arm.
  • Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
  • Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

Exclusion criteria

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat in the upper arm.
  • Excessive skin laxity in the upper arm.
  • Significant scarring in areas to be treated.
  • Significant open wounds or lesions in the treatment areas. 7. Severe or cystic acne in the treatment areas.

Treatment and study plan

Ulthera® System

Device

Focused ultrasound energy delivered below the surface of the skin.

Other names: Ultherapy™ treatment, Ulthera, Inc., Ultrasound treatment for skin tightening

Primary outcomes

  1. Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity

    Time frame: Baseline to 90 days post-treatment

    Improvement in overall lifting and tightening of brachial skin laxity as determined by masked, qualitative assessment of photographs at 90 days post-treatment compared to baseline.

Secondary outcomes

  1. Quantitative Improvement in Skin Laxity

    Time frame: Baseline to 90 days post-treatment

    Assess change in brachial volume based on brachial tissue measurements.

  2. Change in Dermal Thickness

    Time frame: Baseline to 90 days post-treatment

    Based on ultrasonic skin analysis, the change in dermal thickness from baseline to 90 days post-treatment was calculated.

  3. Change in Dermal Thickness

    Time frame: Baseline to180 days post-treatment

    Based on ultrasonic skin analysis, the change in dermal thickness from baseline to 180 days post-treatment was calculated.

  4. Overall Aesthetic Improvement

    Time frame: Baseline to 60 days post-treatment

    Based on Global Aesthetic Improvement Scale (GAIS) Scores; PGAIS completed by a physician assessor, SGAIS completed by the study subject. . The GAIS is a 5-point scale (1-5) describing an overall assessment as follows:

    • - Very Much Improved
    • - Much Improved
    • - Improved
    • - No Change
    • - Worse
  5. Overall Aesthetic Improvement

    Time frame: Baseline to 90 days post-treatment

    Based on Global Aesthetic Improvement Scale (GAIS) Scores; PGAIS completed by a physician assessor, SGAIS completed by the study subject. . The GAIS is a 5-point scale (1-5) describing an overall assessment as follows:

    • - Very Much Improved
    • - Much Improved
    • - Improved
    • - No Change
    • - Worse
  6. Overall Aesthetic Improvement

    Time frame: Baseline to180 days post-treatment

    Based on Global Aesthetic Improvement Scale (GAIS) Scores; PGAIS completed by a physician assessor, SGAIS completed by the study subject. . The GAIS is a 5-point scale (1-5) describing an overall assessment as follows:

    • - Very Much Improved
    • - Much Improved
    • - Improved
    • - No Change
    • - Worse
  7. Patient Satisfaction

    Time frame: Baseline to 90 days post-treatment

    Patient satisfaction was determined by scores on a patient satisfaction questionnaire (PSQ) completed at 90 days post-treatment. Subjects indicated how satisfied they were with study treatment, i.e., Very Satisfied, Satisfied, Dissatisfied, Very Dissatisfied. Pre-treatment and Day 90 post-treatment photographs were available for viewing during the assessment.

  8. Patient Satisfaction

    Time frame: Baseline to 180 days post-treatment

    Patient satisfaction was determined by scores on a patient satisfaction questionnaire (PSQ) completed at 180 days post-treatment. Subjects indicated how satisfied they were with study treatment, i.e., Very Satisfied, Satisfied, Dissatisfied, Very Dissatisfied. Pre-treatment and Day 90 post-treatment photographs were available for viewing during the assessment.

Sponsors and collaborators

Lead sponsor

Ulthera, Inc

Industry

Registry information

Official study title

Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Brachia

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Oct 25, 2012
Registry last updated
Dec 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.